Skip to content
OpenCapital
Get started

Curanex Pharmaceuticals Inc Common Stock CURX Q1 2026 earnings

Reported March 30, 2026 · Before market open

Diluted EPS-$0.12

Next report

Date not yet announced

Versus estimates

Diluted EPS

Q1 2026-$0.12
Q4 2025-$0.12Q3 2025-$0.04

Ask the moment Curanex Pharmaceuticals Inc Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Curanex Pharmaceuticals Inc Common Stock report Q1 2026 earnings?
Curanex Pharmaceuticals Inc Common Stock (CURX) reported Q1 2026 earnings on March 30, 2026 before market open.
What were Curanex Pharmaceuticals Inc Common Stock's Q1 2026 revenue and EPS?
Curanex Pharmaceuticals Inc Common Stock reported diluted EPS of $-0.12 for Q1 2026.
Where can I find Curanex Pharmaceuticals Inc Common Stock's Q1 2026 SEC filings?
You can read the 10-Q periodic report (0001493152-26-022892) directly on SEC EDGAR. The filing index links above go to sec.gov.